CYDY
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- CytoDyn dosed the first patient in a Phase 2a Alzheimer's study evaluating leronlimabJun 11, 2026
- CytoDyn and Natera announced a strategic collaboration for ctDNA-guided development and molecular response analysis in metastatic colorectal cancerJun 4, 2026
- CytoDyn dosed the first patient in the expanded access program for Leronlimab in triple-negative breast cancerApr 27, 2026
- CytoDyn to present on Leronlimab induction of PD-L1 and immune checkpoint inhibitor responses in metastatic triple-negative breast cancer at AACR Special ConferenceSep 25, 2025
- CytoDyn announces encouraging survival data in metastatic colorectal cancer patients previously treated with LeronlimabJul 1, 2025